Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Accumulated Expenses (2021 - 2025)

Biofrontera (BFRI) has 5 years of Accumulated Expenses data on record, last reported at $3.0 million in Q3 2025.

  • For Q3 2025, Accumulated Expenses changed N/A year-over-year to $3.0 million; the TTM value through Sep 2025 reached $3.0 million, changed N/A, while the annual FY2024 figure was $2.4 million, N/A changed from the prior year.
  • Accumulated Expenses reached $3.0 million in Q3 2025 per BFRI's latest filing, up from $2.4 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $5.6 million in Q4 2021 and bottomed at $2.4 million in Q2 2025.
  • Average Accumulated Expenses over 5 years is $3.8 million, with a median of $2.7 million recorded in 2022.
  • The widest YoY moves for Accumulated Expenses: up 55.36% in 2022, down 55.36% in 2022.
  • A 5-year view of Accumulated Expenses shows it stood at $5.6 million in 2021, then plummeted by 55.36% to $2.5 million in 2022, then changed by 0.0% to $2.5 million in 2023, then fell by 2.88% to $2.4 million in 2024, then increased by 22.49% to $3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $3.0 million in Q3 2025, $2.4 million in Q2 2025, and $2.5 million in Q1 2025.